Polycystin-1 promotes PKCα-mediated NF-κB activation in kidney cells

• Published in: Biochemical and biophysical research communications 2006-11, Vol.350 (2), p.257-262
• Main Authors: Banzi, Manuela, Aguiari, Gianluca, Trimi, Viky, Mangolini, Alessandra, Pinton, Paolo, Witzgall, Ralph, Rizzuto, Rosario, Senno, Laura del
• Format: Article
• Language: English
• Subjects: Apoptosis; NF-κB; PKCα; Polycystin-1; Promoter activity; siRNA
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2006.09.042

Polycystin-1 (PC1), the PKD1 gene product, is a membrane receptor which regulates many cell functions, including cell proliferation and apoptosis, both typically increased in cyst lining cells in autosomal dominant polycystic kidney disease. Here we show that PC1 upregulates the NF-κB signalling pathway in kidney cells to prevent cell death. Human embryonic kidney cell lines (HEK293 CTT), stably expressing a PC1 cytoplasmic terminal tail (CTT), presented increased NF-κB nuclear levels and NF-κB-mediated luciferase promoter activity. This, consistently, was reduced in HEK293 cells in which the endogenous PC1 was depleted by RNA interference. CTT-dependent NF-κB promoter activation was mediated by PKCα because it was blocked by its specific inhibitor Ro-320432. Furthermore, it was observed that apoptosis, which was increased in PC1-depleted cells, was reduced in HEK293 CTT cells and in porcine kidney LtTA cells expressing a doxycycline-regulated CTT. Staurosporine, a PKC inhibitor, and parthenolide, a NF-κB inhibitor, significantly reduced the CTT-dependent antiapoptotic effect. These data reveal, therefore, a novel pathway by which polycystin-1 activates a PKCα-mediated NF-κB signalling and cell survival.